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Objectives. This study sought to assess the endothelial function
of long-term coronary artery lesions in patients with Kawasaki
disease (KD).
Background. The vascular function of the coronary arteries in
children with long-term KD remains uncertain. We report our
findings of the vascular response of the coronary arteries to
intracoronary injection of acetylcholine (ACh) in patients with
KD.
Methods. A total of 35 patients (25 patients with KD and 10
control subjects) were examined using coronary angiography.
Individual arteries were divided into four groups according to the
type of the coronary artery lesion: group 1 consisted of 25 sites
with regressed aneurysms. These aneurysms had developed in the
acute stage but had subsequently regressed and demonstrated
normal findings on the follow-up coronary angiogram. Group 2
consisted of 24 sites with persistent aneurysms. Group 3 involved
60 angiographically normal sites in the same patients as those in
group 1 or 2. Group 4 consisted of 30 sites in control subjects who
had congenital heart disease with normal coronary arteries.
During coronary angiography we infused 15 mg of ACh chloride
into the coronary artery. The lumen diameters were measured
using a cine videodensitometric analyzer to study the distensibility
of the coronary artery wall.
Results. The mean (6SD) change in diameter was an increase
of 11.71 6 12.34% in group 3 (coronary arteries without lesions in
patients with KD) and 12.21 6 9.71% in the control group,
demonstrating marked vasodilation in both groups. In contrast,
the changes in the regressed aneurysms of group 1 and in the
persistent aneurysms of group 2 were 22.65 6 12.12% and
20.08 6 6.51%, respectively, demonstrating no change or mild
vasoconstriction. The change in groups 1 and 2 was significantly
less than that in group 3 or in the control group. Group 3 showed
no significant difference from the control group.
Conclusions. These findings suggest that long-term coronary
artery lesions, even after aneurysm regression, may have impaired
endothelial function. A long-term follow-up study for those pa-
tients is essential.
(J Am Coll Cardiol 1998;31:1074–80)
©1998 by the American College of Cardiology
Coronary artery aneurysms develop in 10% to 20% of patients
with acute Kawasaki disease (KD) (1). We have reported that
50% of patients with coronary aneurysms demonstrated re-
gression of the aneurysms on follow-up coronary angiography,
with completely normal findings (2). The histopathologic find-
ings of a regressed aneurysm include marked thickening in the
intima with proliferation of smooth muscle cells (3). These
histopathologic changes were similar to findings in arterioscle-
rosis. However, the vascular function of these regressed lesions
has remained uncertain.
Acetylcholine (ACh) has been reported to dilate normal
coronary arteries by promoting the release of vasorelaxant
substances such as nitric oxide from the endothelium (4). In
coronary arteriosclerosis, endothelium-dependent vasodilation
is impaired, and paradoxic vasoconstriction has been demon-
strated by ACh (5). In this study, we evaluated the vascular
function of long-term coronary artery lesions in patients with
KD, using an intracoronary infusion of ACh.
Methods
Study subjects. From June 1995 to August 1996, a total of
35 patients received coronary artery angiography before and
after intracoronary infusion of ACh. The study group consisted
of 25 patients with KD (17 boys and 8 girls) and 10 patients
with congenital heart disease as control subjects. The patients
had suffered from KD from 5 months to 4.4 years of age (mean
1.5 years) and have been followed for 13.4 6 3.8 years at
Kurume University Hospital. Coronary angiography was first
performed for each patient with KD just after the acute stage
of the illness to evaluate coronary artery lesions. The follow-up
coronary angiographic study was done 1 to 12 years after the
first coronary angiogram. The 25 patients with KD consisted of
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13 with regressed coronary aneurysms, as demonstrated by
normal coronary angiographic findings within 1 to 2 years, and
12 with persistent coronary aneurysms. Patients with coronary
artery stenosis were excluded from the study. All patients with
KD received 30 mg/kg body weight per day of aspirin during
the acute stage of the illness, which was reduced to 5 mg/kg per
day while the patient demonstrated abnormal coronary angio-
graphic findings. No high dose gamma globulin was given to
the patients in this study, because all patients had KD before
the first report of this treatment (6).
As a control group, 10 patients (mean age 13.1 6 2.4 years,
matched to the mean age of the patients with KD) with
congenital heart disease were included in this study: three with
a small ventricular septal defect, five with a patent ductus
arteriosus and two with mild pulmonic stenosis. All of these
control subjects had normal coronary arteries on coronary
angiography. Written, informed consent was obtained from the
parents of all patients.
Coronary angiography. A 6F sheath was inserted percuta-
neously into the femoral artery, through which a 5F Judkins-
Kato pediatric coronary angiography catheter was advanced up
to the ostium of the right or left coronary artery using the
Judkins technique. After diagnostic heart catheterization using
model KXO-2050 (Toshiba Corp., Tokyo), coronary angiogra-
phy was performed with injection of iohexol manually under
electrocardiographic monitoring. A cardiac pacing catheter
was positioned in the right ventricule to avoid bradyarrythmias
during injection of ACh. The adequate dosage of ACh re-
quired to assess vascular function is uncertain in children.
Preliminarily, we studied the effects from different dosages (5,
15, 30 and 50 mg) in a normal coronary artery and in regressed
coronary aneurysms in four children with KD. When we used
50 mg of ACh, the normal coronary artery became constricted,
and when we used 5 mg of ACh the normal coronary artery did
not dilate. When we used 15 and 30 mg of ACh, significant
dilation was recognized in the normal coronary arteries, and
vasoconstriction appeared in the regressed aneurysms. So, we
chose a lower dose (15 mg) of ACh in this study. Thus, 15 mg
of ACh chloride (Daiichi Seiyaku, Tokyo) was diluted in 5 ml
of warm 0.9% saline solution (to produce a coronary blood
concentration of ;3.0 3 1026 mol/liter) and was infused
through a Judkins-Kato catheter into the left coronary artery,
over 30 s. The second coronary angiographic study was per-
formed in the left coronary artery at 30 s after completion of
the ACh infusion.
Study sites of coronary artery lesions. We classified our
patients into four groups according to the presence or absence
of coronary artery lesions (Fig. 1). Group 1 involved 25 sites of
regressed coronary artery aneurysms in 13 patients. In these
patients, the coronary artery aneurysms in the early stage had
become regressed, and on a follow-up coronary angiography 1
to 2 years later, they demonstrated normal findings. We
measured the lumen diameter at the same sites at the point
where the maximal diameter of the aneurysms had existed in
the acute stage of KD. Group 2 involved 24 sites of persistent
coronary aneurysms in 12 patients. Group 3 involved 60
angiographically normal sites of the coronary artery in the
same 25 patients with KD as those in group 1 or 2, who had
either regression or persistence of aneurysms. In these patients
we chose other normal sites where coronary aneurysms had not
developed in the acute stage of KD and also demonstrated
normal findings at follow-up coronary angiography. These
normal sites included coronary segments located at least
10 mm from the site of previous aneurysms or opposite a
previous aneurysm site, which is normal for a coronary artery
during the acute phase of KD. Group 4 involved 30 sites in 10
patients (control group) with congenital heart disease who
demonstrated normal coronary angiographic findings.
Angiographic analysis. We measured the lumen diameter
of several sites with large- or moderate-sized left coronary
arteries in the same patient, such as in the main trunk of the
left coronary artery, the left anterior descending coronary
artery, the left circumflex artery and the main right coronary
artery, where coronary aneurysms in KD are likely to develop.
For measurement, we used a cine frame at the end-diastolic
phase. The lumen diameters were measured using a cine
analysis system computer (CARDIO-500, Kontron Electronik,
Germany) for delineation of the coronary cineangiograms.
Abbreviations and Acronyms
ACh 5 acetylcholine
KD 5 Kawasaki disease
Figure 1. Percent change in coronary artery diameter after intracoro-
nary infusion of ACh in each group. Data are presented as mean
value 6 SEM.
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Representative angiograms of a left coronary artery before and
after ACh infusion are shown in Figures 2, 3 and 4. Each site
was measured three times, and the mean value was used for
statistical analysis. A change in the coronary artery diameter
was calculated using the following formula: percent change of
each segment 5 (diameter after infusion 2 diameter before
infusion)/diameter before infusion 3 100. The percent change
in each patient was defined as the mean percent change of
overall segments.
Statistical analysis. Analysis of variance for repeated mea-
surements with the Bonferroni correction was used to compare
the groups. The Student t test was used for two-way compari-
son of data, and p , 0.05 was considered significant. Previous
studies reported that different segments of the coronary arter-
ies had different responses to ACh (7,8). Therefore, in each
group we calculated the percent change in each segment,
independent of the subjects from which they were taken, and
compared this percent change in each segment among the
groups. To support our assumption that each segment in the
same patient behaves independently, we also compared the
percent change in each patient, which we calculated by taking
the average of these percent changes in each segment in the
same patient.
Results
Changes in coronary artery lumen diameter. The percent
change in the coronary artery diameter in each group is shown
in Figure 1 and Table 1. The mean (6SD) changes in the
coronary artery diameter in each segment were 22.65 6
12.12% in the regressed aneurysms of group 1, 20.08 6 6.51%
in the persistent aneurysms of group 2, 11.71 6 12.34% in the
angiographically normal sites of group 3 and 12.21 6 9.71% in
group 4 (control). The persistent aneurysms of group 2 dem-
onstrated almost no change in the lumen diameter and signif-
icantly less change than that in the control group (p , 0.001)
or the group with normal sites (p , 0.001). In group 1 with
regressed aneurysms, mild vasoconstriction was recognized,
which was significantly different from that in group 3 with
normal sites (p , 0.001) or group 4 (control) (p , 0.001). No
significant difference was recognized between the regressed
aneurysms of group 1 and the persistent aneurysms of group 2.
There were no significant differences between groups 2 and 4.
The percent changes in overall segments of the coronary artery
in each patient were 24.32 6 11.07% in group 1, 20.30 6
5.80% in group 2, 11.49 6 7.10% in group 3 and 12.19 6 6.35%
in group 4. Significantly less change was not noted in group 4
(p , 0.001) and group 3 (p , 0.001). In group 1, there was a
significant difference due to mild vasoconstriction, as com-
pared with group 3 (p , 0.001) and group 4 (p , 0.001). There
was no significant difference between groups 1 and 2. There
was no significant difference between groups 3 and 4. A similar
trend still existed after the mean percent change in overall
segments of the coronary artery in each patient was used to
eliminate effects due to multiple points from the same patient.
To support our assumption that each segment in the same
Figure 2. Coronary angiograms of the left coronary artery
before (A) and after (B) injection of ACh in a child with small
patent ductus arteriosus and a normal coronary artery. The
coronary artery was significantly dilated with ACh infusion at
the sites in the left main coronary artery, the left anterior
descending coronary artery and the left circumflex artery
(arrows 1, 2 and 3, respectively).
Figure 3. Coronary angiograms of the left coronary artery in
a patient with regressed coronary aneurysms. A, This boy had
an aneurysm (arrowhead with asterisk) in the left anterior
descending coronary artery in the acute stage of KD (at 1.6
years of age), which subsequently regressed. B, Twelve years
later, a coronary angiogram demonstrated a regressed aneu-
rysm (arrowhead 2 with asterisk) that showed normal find-
ings before ACh infusion. C, After infusion of ACh, signif-
icant vasoconstriction at the site of the regressed coronary
aneurysm was demonstrated (arrowhead 2 with asterisk)
(decreased by 25% in diameter). The sites of the intact
coronary artery (arrowheads 1 and 3) demonstrated mild
vasodilation (increased in diameter by 8% and 5%, respec-
tively).
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patient behaves independently, we also compared the percent
change in each patient, which we calculated by taking the
average of these percent changes in each segment in the same
patient.
Complications. The heart rate and aortic pressure did not
change during this study. Changes in the ST segment were
observed on the electrocardiograms of four patients during
intracoronary infusion of ACh, but lasted only a few seconds.
All patients had no chest pain, no palpitations and no arrhyth-
mias during or after infusion of ACh.
Discussion
The long-term prognosis and natural history of KD, partic-
ularly in patients with normal coronary arteries or regressed
coronary aneurysms, remains uncertain at the present time.
We have reported that .50% of aneurysms regress within
several years and demonstrate normal angiographic findings
(9). However, on histologic examination, marked thickening of
the intima is found, which may be caused by the proliferation
of smooth muscle cells. This proliferation may then produce
the normal-sized lumen in the coronary artery (3,10). Intravas-
cular ultrasound imaging of the sites of regressed coronary
aneurysms has also demonstrated intimal thickening (11).
These findings are similar to those found in arteriosclerosis. In
this study we evaluated the vascular function of the coronary
artery after KD using intracoronary injection of ACh. Acetyl-
choline is believed to dilate normal blood vessels by promoting
the release of vasorelaxant substances such as nitric oxide (12).
In contrast, if the endothelial function is impaired, ACh
directly causes medial smooth muscle constriction. In coronary
arteriosclerosis, endothelium-dependent vasodilation is im-
paired and paradoxic vasoconstriction is induced by ACh (13).
In the present study, the normal sites of group 3 and control
sites of group 4 demonstrated marked vasodilation due to ACh
administration, which suggested that these lesions had normal
endothelial function. The sites of the persistent aneurysms of
group 2 presented an abnormal response to ACh and showed
no change or mild vasoconstriction of the coronary artery.
Even after regression of aneurysms, as indicated by angio-
graphically normal findings, the responses to ACh at these sites
showed mild vasoconstriction of the coronary artery or weak
dilation in several patients. These responses suggested that the
coronary artery had impaired endothelium-dependent relax-
ation in the sites of aneurysm regression after KD. To further
assess the endothelial function, the vascular responses of sites
with lesions to isosorbide dinitrate, in addition to ACh, should
be studied. If only the endothelium is impaired, ACh should
cause paradoxic vasoconstriction and isosorbide dinitrate
should produce vasodilation. In this study we did not inject
ACh and isosorbide dinitrate concurrently, and this is a
limitation of our study. However, we previously investigated
the ability of the coronary artery to dilate with intracoronary
infusion of isosorbide dinitrate after KD (14). In the group
with persistent aneurysms or stenosis, the mean observed
dilation was significantly less than that in the group with
normal coronary arteries. In the present study those lesions
with persistent coronary aneurysms demonstrated almost no
changes with ACh infusion. These two results suggest that a
portion of the persistent coronary aneurysms may have had
increased coronary arterial stiffness. In the patients with
regressed aneurysms, the coronary artery was dilated using
isosorbide dinitrate, although the coronary artery was dilated
more in the control group. Our studies suggest that the
regressed coronary artery showed pathologically abnormal
responses to ACh and may have endothelial dysfunction with
impairment in endothelium-dependent vasodilation. Smooth
muscle dysfunction may also be present.
In this study, as the unit of analysis, we used the lesion of
the coronary artery instead of the patient, because the aim of
our study was to evaluate the vascular function of different
lesions such as regressed aneurysms, persistent aneurysms and
angiographically normal sites in the same patient. As shown in
Figure 3, as a representative case, the lesion of the regressed
aneurysm demonstrated marked vasoconstriction, whereas the
portion of the intact coronary artery in the same patient
revealed paradoxic vasodilation. Also, in the patient shown in
Figure 4, the site of persistent coronary aneurysm demon-
strated no change with ACh infusion, but the portion with
angiographically normal findings showed dilation of the arter-
Figure 4. This patient was affected by KD at 4 years of age
and developed an aneurysm in the left anterior descending
coronary artery. Coronary angiograms at 18 years of age
before (A) and after (B) injection of ACh demonstrated no
change of the lumen diameter at the site of a persistent
aneurysm (arrowhead 1 with asterisk). However, the normal
sites of the coronary artery demonstrated mild dilation
(arrowheads 2 and 3).
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Table 1. Percent Changes in Coronary Artery Lumen Diameter in Response to Acetylcholine
Pt. No.
Group 1* Group 2† Group 3‡ Group 4§
Site
D in
Segment
Mean D in
Each Patient Site
D in
Segment
Mean D in
Each Patient Site
D in
Segment
Mean D in
Each Patient Site
D in
Segment
Mean D in
Each Patient
1 S5 7.77 S1 11.50
S6 2.26 S2 15.57
5.01 S3 16.23 14.43
2 S5 29.76 S1 3.82
S6 216.00 S2 2.34
212.88 S3 4.36 3.51
3 S1 8.11 S5 38.50
S3 10.55 S7 21.83
9.33 S13 15.69 25.34
4 S1 210.10 S5 14.73
S2 27.31 S6 1.62
S3 26.43 27.95 8.18
5 S1 225.00 S5 5.23
S7 8.23
225.00 S11 1.43 4.96
6 S2 4.38 S1 22.63
S6 12.92 S3 20.89
S7 26.41 3.63 21.76
7 S6 214.80 S1 1.35
S2 1.24
214.80 S3 5.95 2.85
8 S5 12.17 S7 15.93
S6 12.82 S13 18.33
S3 28.92 5.36 17.13
9 S5 8.83 S1 7.99
S2 22.22
8.83 S3 21.20 17.14
10 S5 210.80 S2 7.86
S1 6.70 22.05 S7 0.00 3.93
11 S3 214.00 S5 2.10
S6 5.75
214.00 S7 13.71 7.19
12 S1 216.79 S5 23.95
S2 211.81 214.30 S6 2.81 13.38
13 S1 9.30 S5 16.03
S2 24.00 2.65 S6 4.36 10.20
Mean 22.65 24.32
14 S5 211.06 S1 1.29
S6 210.50 210.78 S2 1.34 1.32
15 S6 0.08 S1 5.03
S11 28.84 24.38 S2 21.00 13.02
16 S1 0.90 S5 16.67
S6 19.35
0.90 S7 20.29 18.77
17 S1 9.30 S5 28.22
S2 12.05 S6 26.48
10.68 S7 28.83 27.84
18 S5 21.51 S7 13.59
S6 25.14 23.33 S13 7.93 10.76
19 S5 12.87 S7 15.73
S6 20.20 S13 5.90
S11 0.08 4.25 10.82
20 S5 6.89 S1 10.97
S6 2.36
S7 21.52 2.58 10.97
21 S1 21.02 S5 9.20
S2 2.51 0.75 S6 12.86 11.03
22 S2 24.94 S5 1.19
S3 23.50 24.22 S6 22.57 11.88
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ies. For the group with normal coronary arteries (group 3) and
the control group (group 4), we measured several sites of
coronary arteries in the same subject, assuming that each
segment in the same patient behaves independently, because
previous reports revealed that different segments of the coro-
nary arteries had different responses to ACh (7,8). These
different responses in each segment, however, may not directly
explain the independence of the response. Hence, we also
compared the vascular response using the mean percent
change in overall segments of the coronary artery in each
patient to eliminate the potential problem of multiple mea-
surements in the same patient, and we found the same trend.
These findings suggested that the response or behavior to ACh
varied independently in the different lesions of the coronary
arteries in the same patient. We believe that such endothelial
dysfunction does not exist uniformly in all of the coronary
arteries after KD, and that the endothelial function of coro-
nary arteries should be considered in each lesion of the
arteries. Based on this reasoning, the unit of statistical analysis
of this study was the coronary artery lesion and not the patient.
In the control group with normal coronary arteries, we mea-
sured several sites of the coronary arteries in the same subject,
Table 1. (continued).
Pt. No.
Group 1* Group 2† Group 3‡ Group 4§
Site
D in
Segment
Mean D in
Each Patient Site
D in
Segment
Mean D in
Each Patient Site
D in
Segment
Mean D in
Each Patient Site
D in
Segment
Mean D in
Each Patient
23 S2 6.07 S1 16.44
S6 5.62 S3 21.33
5.85 S7 3.82 13.86
24 S2 24.33 S3 1.76
S6 26.93 25.63 S13 1.91 1.76
25 S6 21.27 S2 11.21
S3 1.50
21.27 S13 2.95 5.22
Mean 20.08 20.30 11.71 11.49
26 S1 15.00
S5 16.30
S6 15.47 15.59
27 S1 3.09
S2 4.42
S6 3.89 3.80
28 S1 27.00
S5 13.87
S6 12.50 17.79
29 S2 20.18
S3 20.75
S6 17.24 19.39
30 S1 21.34
S3 16.60
S11 10.81 16.25
31 S2 5.94
S3 22.81
S6 21.07 16.61
32 S1 1.60
S5 1.32
S6 1.39 1.44
33 S2 6.11
S3 5.65
S6 6.00 5.92
34 S1 12.30
S2 10.41
S6 9.66 10.79
35 S5 13.60
S6 15.03
S7 14.84 14.29
Mean 12.21 12.19
*Group 1 with regressed aneurysms. †Group 2 with persistent aneurysms. ‡Group 3 with normal coronary arteries. §Group 4 as control group. Data are presented
as the percent change in coronary artery diameter. Pt. 5 patient; S1 to S13 5 segment of the coronary artery according to the American Heart Association Committee
Report; D 5 change.
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because there were no data on the vascular response to ACh in
the different portions of the normal coronary artery in chil-
dren. Because this resulted in almost identical behavior in
response to ACh, we used these patients’ mean value for
statistical analyses.
At the sites of persistent coronary aneurysms, the diameter
of the vascular lumen did not change with ACh infusion. These
sites did not demonstrate marked dilation or marked constric-
tion in the sites of coronary aneurysms. These findings suggest
that both impaired endothelial function and smooth muscle
dysfunction, or increased coronary arterial stiffness, contrib-
uted to this phenomenon. We excluded patients with stenotic
lesions in the coronary artery from this study to avoid causing
unnecessary ischemic events due to constriction of such lesions
during ACh infusion.
In this study, the sites of normal coronary arteries in
patients with KD, where coronary aneurysms had not devel-
oped at the acute stage and which had demonstrated normal
coronary angiographic findings on follow-up, responded nor-
mally to ACh. These findings suggest that these portions of the
coronary arteries had normal endothelial function. However, it
should be mentioned that Mitani et al. (15) described that a
normal portion of the coronary artery after KD constricted due
to ACh infusion, although the number of patients they studied
was small. We should further investigate patients with normal
coronary arteries who did not develop coronary aneurysms
from acute KD.
Long-term clinical implications. It is evident that coronary
artery lesions after long-term KD have impaired endothelial
function. However, it is uncertain how long it persists or
whether it gradually improves over time. In this study we did
not compare the vascular response to ACh in the same patient
over time; however, we speculate that this endothelial dysfunc-
tion may persist longer and may develop into arteriosclerosis.
Long-term follow-up is necessary, not only for patients with
abnormal coronary lesions but also for patients with regressed
aneurysms. It has been reported that most angiographically
normal coronary arteries in subjects .30 years old have
endothelial dysfunction, as demonstrated by an abnormal
response to ACh, and therefore have a risk for developing
early coronary arteriosclerosis (7). A long-term follow-up study
of patients with KD should focus on the possible development
of arteriosclerosis and ischemic heart disease in adulthood.
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